Cognitive Functional Therapy versus Kinetic Control Training for non-specific chronic low back pain

Effects of Cognitive Functional Therapy Versus Kinetic Control Training on Pain, Disability, Movement Control in Patients With Non-specific Low Back Pain

Not applicable Interventional Lahore University of Biological and Applied Sciences · NCT07282925

This will test whether Cognitive Functional Therapy or Kinetic Control Training better reduces pain, disability, and movement-control problems in adults with chronic non-specific low back pain.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment70 (estimated)
Ages19 Years to 39 Years
SexAll
SponsorLahore University of Biological and Applied Sciences Academic / other
Locations1 site (Lahore, Punjab Province)
Trial IDNCT07282925 on ClinicalTrials.gov

What this trial studies

Researchers will compare two rehabilitation approaches—Cognitive Functional Therapy (CFT) and Kinetic Control Training (KCT)—in adults with chronic non-specific low back pain. Participants aged 19–39 with at least three months of symptoms and a Roland-Morris Disability Questionnaire score of 6 or higher will be assigned to one of the two groups and will attend supervised sessions three times per week for eight weeks at a private physical therapy clinic in Lahore. Primary outcomes include pain intensity, disability (RMDQ), and movement-control measures, with secondary outcomes such as pain catastrophizing and self-efficacy measured before and after the intervention. The trial aims to determine whether the multidimensional, behavioral-focused CFT offers advantages over the movement-control–oriented KCT in improving symptoms and function.

Who should consider this trial

Good fit: Ideal candidates are adults aged 19–39 with non-specific chronic low back pain for at least three months, a Roland-Morris score of 6 or higher, and no red-flag conditions, inflammatory or progressive neurological disease, or pregnancy.

Not a fit: Patients whose pain is due to a specific lumbar pathology, those with primary leg pain, inflammatory disease, progressive neurological disorders, red-flag conditions (e.g., cancer or fracture), pregnant women, or people outside the 19–39 age range are unlikely to benefit from these interventions in this trial.

Why it matters

Potential benefit: If one approach proves superior, clinicians could use that therapy to reduce pain and disability and improve movement control for people with chronic non-specific low back pain.

How similar studies have performed: Previous trials and cohort studies suggest CFT can reduce pain and disability for some patients, while evidence for Kinetic Control Training is more limited and direct head-to-head comparisons are scarce.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of both sexes
* Aged between 19 to 39
* Patients who score 6 points or higher on the Roland-Morris Disability Questionnaire (RMDQ) at the time of screening
* Patients who will have Non-Specific Chronic Low Back pain for at least 3 months duration

Exclusion Criteria:

* If the primary pain area is not the lumbar spine.
* If leg pain is the primary problem.
* If patient have inflammatory disease.
* If patient have progressive neurological disease.
* If patient have red flag disorders (malignancy/cancer, traumas such as fracture).
* Pregnant females.

Where this trial is running

Lahore, Punjab Province

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Low Back PainNon Specific Chronic Low Back PainNon Specific Low Back PainChronic Low Back PainCognitive Functional TherapyKinetic Control TrainingPainDisability
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.